Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Computational and Structural Biotechnology Journal is a premier open-access journal published by Elsevier, focusing on the intersection of computer science and molecular biology. Since its inception in 2012, the journal has established itself as a leading platform for innovative research, featuring groundbreaking studies in biochemistry, biophysics, biotechnology, and genetics. With a remarkable Q1 ranking in multiple categories, including Biochemistry and Genetics, it stands out for its high impact, evidenced by its strong Scopus ranking percentile scores. As a vital resource for researchers, professionals, and students, the journal aims to foster the dissemination of essential findings that leverage computational techniques to explore complex biological systems. In a rapidly evolving scientific landscape, Computational and Structural Biotechnology Journal serves as an indispensable resource for those looking to contribute and stay abreast of major advancements in the field.

CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES is a premier journal published by Tech Science Press, dedicated to advancing knowledge in the fields of computer science applications, modeling and simulation, and software engineering. With an impressive convergence of research from 2000 to 2024, this journal stands out as a vital resource for researchers, professionals, and students alike, fostering innovation and collaboration in computational methodologies. The journal currently holds a Q3 category ranking in multiple disciplines according to the latest metrics, including Scopus, which reflects its growing significance in the academic community. By providing a platform for high-quality research and open discourse, CMES aims to enhance the understanding of complex systems through effective modeling techniques and computational tools. Despite its current classification under open access, the journal remains a cornerstone for those looking to deepen their expertise in cutting-edge computational engineering and science.

NATURE BIOTECHNOLOGY, an esteemed journal published by NATURE PORTFOLIO, stands at the forefront of innovation in biotechnological research since its inception in 1989. With an impressive impact factor reflecting its preeminent status—ranked in the Q1 quartile across multiple categories including Applied Microbiology, Bioengineering, Biomedical Engineering, Biotechnology, and Molecular Medicine—this journal is a pivotal resource for researchers and professionals aiming to advance the boundaries of biotechnology. The journal is highly regarded, boasting Scopus rankings in the 99th percentile within its categories. NATURE BIOTECHNOLOGY provides a platform for disseminating cutting-edge findings, with open access options that enhance the visibility and accessibility of its content to a global audience. The scope of the journal encapsulates a diverse range of topics from genetic engineering to pharmaceutical developments, ensuring comprehensive coverage of emerging biotechnological advances. As the field continues to evolve, NATURE BIOTECHNOLOGY remains committed to publishing groundbreaking research that shapes the future of science and industry.

Current Opinion in Biomedical Engineering is a renowned journal published by Elsevier, focusing on the cutting-edge developments and critical assessments in the fields of biomedical engineering and related disciplines. With an ISSN of 2468-4511, it provides a valuable platform for researchers and professionals to disseminate their insights and discoveries in areas such as bioengineering, biomaterials, and medicine. Its impressive impact factor positions it in the Q2 category for several fields, including Bioengineering and Biomedical Engineering, highlighting its influence and relevance in ongoing scientific dialogues. The journal’s unique format of opinion pieces and reviews encourages innovative thinking and fosters collaboration among experts. As an essential resource for those engaged in the life sciences and engineering, Current Opinion in Biomedical Engineering serves to stimulate discussion, promote knowledge exchange, and drive advancements in biomedical applications. Set in the Netherlands at Radarweg 29, 1043 NX Amsterdam, the journal is accessible through various academic platforms, enabling a global readership to engage with the latest scholarly work in this dynamic field.

Biocybernetics and Biomedical Engineering, published by ELSEVIER in the Netherlands, is a prestigious journal that stands at the forefront of the intersecting fields of biomedical engineering and artificial intelligence. With an impressive Impact Factor that places it in the Q1 category for Biomedical Engineering, this journal not only ranks 17th out of 303 in Scopus but also boasts a remarkable percentile ranking of 94th, highlighting its influence and relevance within the scientific community. Since its inception in 2008, Biocybernetics and Biomedical Engineering has aimed to publish cutting-edge research that integrates principles of cybernetics with technological advancements in health care, thereby fostering innovations that improve patient outcomes. Dedicated to advancing knowledge in biomedical technology, the journal serves as a vital resource for researchers, professionals, and students seeking to explore the latest developments and methodologies in the field.

Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.

Biomedical Engineering and Computational Biology is a premier journal dedicated to advancing the fields of biomedical engineering and computational biology through rigorous research and innovation. Published by SAGE Publications Ltd, this Open Access journal has been providing a platform for the dissemination of high-quality research since 2009, enabling wider accessibility and collaboration among scientists and practitioners around the globe. With its comprehensive scope that encompasses the intersection of engineering principles and biological systems, the journal plays a critical role in fostering advancements in healthcare technologies and computational methods. Researchers, professionals, and students alike can take advantage of its rich repository of articles that contribute significantly to the understanding and application of complex biological data through computational techniques. The journal’s commitment to excellence is reflected in its high visibility within the scientific community, making it an essential resource for those looking to stay at the forefront of this dynamic field.

BIOTECHNOLOGY ADVANCES is a premier, peer-reviewed journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing knowledge in the rapidly evolving fields of biotechnology and bioengineering. With an ISSN of 0734-9750 and an E-ISSN of 1873-1899, this esteemed journal covers a wide spectrum of topics relevant to applied microbiology, molecular biology, and biochemical innovation. Recognized for its academic rigor, it holds a distinguished position in the top quartile (Q1) in multiple categories, including Applied Microbiology and Biotechnology, Bioengineering, and Biotechnology, further evidenced by its high rankings in Scopus, where it ranks #3/127 in Applied Microbiology and Biotechnology and #7/311 in Biotechnology. Researchers and professionals in the field value the journal not only for its comprehensive coverage of cutting-edge research but also for its commitment to disseminating critical findings and fostering collaboration. While BIOTECHNOLOGY ADVANCES currently operates under a subscription model, its potential impact on future innovations in biotechnology cannot be overstated, making it an essential resource for anyone interested in the forefront of biotechnological advancements.